Association of the serotonin transporter and receptor gene polymorphisms in neuropsychiatric symptoms in Alzheimer disease.

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Archives of Neurology

• Publication date

  2004-08-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1001/ARCHNEUR.61.8.1249PMID 15313842
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The 5-HTTPR*S/*L polymorphism and aggressive behavior in Alzheimer disease.

  2001cited by this paper
• Role of serotonin in the behavioral and psychological symptoms of dementia.

  2001cited by this paper
• Association between 5-HT(2A) receptor polymorphism and psychotic symptoms in Alzheimer's disease.

  2001cited by this paper
• The 5-HTTPR Polymorphism Confers Liability to a Combined Phenotype of Psychotic and Aggressive Behavior in Alzheimer Disease

  2001cited by this paper
• Neuropsychiatric disturbance in Alzheimer's disease clusters into three groups: the Cache County study

  2001cited by this paper
• Pharmacogenetic prediction of clozapine response.

  2000cited by this paper
• Association between 5-HT2A receptor polymorphism and psychotic symptoms in Alzheimer's disease

  2000cited by this paper
• Olanzapine treatment of psychotic and behavioral symptoms in patients with Alzheimer disease in nursing care facilities: a double-blind, randomized, placebo-controlled trial. The HGEU Study Group.

  2000influential reference
• Nursing home placement is related to dementia progression

  1999cited by this paper
• A randomized trial of risperidone, placebo, and haloperidol for behavioral symptoms of dementia

  1999cited by this paper
• 5-HT2A and 5-HT2C receptor polymorphisms and psychopathology in late onset Alzheimer's disease.

  1998influential reference
• The impact of the Symptoms of dementia on caregivers

  1997cited by this paper
• Allelic functional variation of serotonin transporter expression is a susceptibility factor for late onset Alzheimer's disease

  1997cited by this paper
• Association of Anxiety-Related Traits with a Polymorphism in the Serotonin Transporter Gene Regulatory Region

  1996cited by this paper
• Polymorphism in serotonin transporter gene associated with susceptibility to major depression.

  1996cited by this paper
• The spectrum of behavioral changes in Alzheimer's disease

  1996cited by this paper
• Association between clozapine response and allelic variation in the 5-HT2C receptor gene

  1995cited by this paper
• The Neuropsychiatric Inventory

  1994cited by this paper
• An MspI polymorphism in the hyman serotonin receptor gene (HTR2): detection by DGGE and RFLP analysis.

  1992cited by this paper
• Possible neurotransmitter basis of behavioral changes in alzheimer's disease

  1988cited by this paper
• Clinical diagnosis of Alzheimer's disease

  1984cited by this paper
• “Mini-mental state”: A practical method for grading the cognitive state of patients for the clinician

  1975cited by this paper

• Plasma biomarkers in neuropsychiatric syndromes: A narrative review

  2025cites this paper
• Neurobiology of Behavioral and Psychological Symptoms of Dementia

  2025cites this paper
• Monoamine alterations in Alzheimer’s disease and their implications in comorbid neuropsychiatric symptoms

  2024cites this paper
• Brexpiprazole: A new option in treating agitation in Alzheimer's dementia—Insights from transgenic mouse models

  2024cites this paper
• Neuropsychiatric Symptoms of Alzheimer’s Disease: An Anatomic-Genetic Framework for Treatment Development

  2023cites this paper
• Generation and Characterization of a Human-Derived and Induced Pluripotent Stem Cell (iPSC) Line from an Alzheimer’s Disease Patient with Neuropsychiatric Symptoms

  2023cites this paper
• Promising candidates from drug clinical trials: Implications for clinical treatment of Alzheimer's disease in China

  2022cites this paper
• The Neurodegenerative Elderly Syndrome (NES) hypothesis: Alzheimer and Parkinson are two faces of the same disease

  2022cites this paper
• Exercise interventions ameliorate neuropsychiatric symptoms in dementia: A meta-analysis

  2022cites this paper
• Alzheimer's Disease-Related Psychosis: An Overview of Clinical Manifestations, Pathogenesis, and Current Treatment.

  2022cites this paper
• Serotonin Receptor Gene Polymorphisms Are Associated with Cerebrospinal Fluid, Genetic, and Neuropsychological Biomarkers of Alzheimer’s Disease

  2022cites this paper
• Cannabinoids for Agitation in Alzheimer's Disease.

  2021cites this paper
• Multifunctional Arylsulfone and Arylsulfonamide-Based Ligands with Prominent Mood-Modulating Activity and Benign Safety Profile, Targeting Neuropsychiatric Symptoms of Dementia

  2021cites this paper
• Protein-protein interactions underlying the behavioral and psychological symptoms of dementia (BPSD) and Alzheimer’s disease

  2020cites this paper
• Clinical Aspects of Neurobehavioral Symptoms of Dementia

  2020cites this paper
• The role of monoamine oxidase A in the neurobiology of aggressive, antisocial, and violent behavior: a tale of mice and men.

  2020cites this paper
• Serotonin and aggression—an update

  2020cites this paper
• Neurodegenerative Disease Caregivers' 5-HTTLPR Genotype Moderates the Effect of Patients' Empathic Accuracy Deficits on Caregivers' Well-Being.

  2019cites this paper
• Escitalopram for agitation in Alzheimer's disease (S‐CitAD): Methods and design of an investigator‐initiated, randomized, controlled, multicenter clinical trial

  2019cites this paper
• Association of Serotonin2c Receptor Polymorphisms With Antipsychotic Drug Response in Schizophrenia

  2019cites this paper
• Pimavanserin in Alzheimer's Disease Psychosis: Efficacy in Patients with More Pronounced Psychotic Symptoms

  2018cites this paper
• Biomarkers of agitation and aggression in Alzheimer's disease: A systematic review

  2018cites this paper
• Behavioral Symptoms of Dementia

  2018cites this paper
• Interactions Among Polymorphisms of Susceptibility Loci for Alzheimer’s Disease or Depressive Disorder

  2018cites this paper
• Neuropsychiatric Symptoms of Major or Mild Neurocognitive Disorders

  2018cites this paper
• Evaluation of the safety, tolerability, and efficacy of pimavanserin versus placebo in patients with Alzheimer's disease psychosis: a phase 2, randomised, placebo-controlled, double-blind study.

  2018cites this paper
• The neurochemistry of agitation in Alzheimer's disease: a systematic review.

  2018cites this paper
• Astrocytic transporters in Alzheimer's disease.

  2017cites this paper
• The Association between 5HT2A T102C and Behavioral and Psychological Symptoms of Dementia in Alzheimer's Disease: A Meta-Analysis

  2017cites this paper
• Genetics of psychosis of Alzheimer disease

  2017cites this paper
• Neuroticism, depression, and anxiety traits exacerbate the state of cognitive impairment and hippocampal vulnerability to Alzheimer's disease

  2017cites this paper
• Motorische Unruhe bei Demenz

  2016cites this paper
• The neurobiological basis of human aggression: A review on genetic and epigenetic mechanisms

  2016cites this paper
• Association Study and Meta-Analysis of Polymorphisms, Methylation Profiles, and Peripheral mRNA Expression of the Serotonin Transporter Gene in Patients with Alzheimer's Disease

  2016cites this paper
• Pharmacological Management of Agitation and Aggression in Alzheimer's Disease: A Review of Current and Novel Treatments.

  2016cites this paper
• Cytogenetic Analysis and Screening of ApoE and Neurotransmitters in Alzheimer’s Patients in Tamil Nadu Population

  2016cites this paper
• Biomarkers of aggression in dementia.

  2016cites this paper
• Yokukansan improves behavioral and psychological symptoms of dementia by suppressing dopaminergic function

  2016cites this paper
• Principles and management of neuropsychiatric symptoms in Alzheimer’s dementia

  2015cites this paper
• Platelets in Alzheimer’s Disease

  2015cites this paper
• The 5-HTTLPR variant in the serotonin transporter gene modifies degeneration of brain regions important for emotion in behavioral variant frontotemporal dementia

  2015cites this paper
• Aggressive behavior: Genetic and physiological mechanisms

  2015cites this paper
• Short alleles, bigger smiles? The effect of 5-HTTLPR on positive emotional expressions.

  2015cites this paper
• Epigenetics and Bruxism: Possible Role of Epigenetics in the Etiology of Bruxism.

  2015cites this paper
• Genetic variations in the serotoninergic system and environmental factors contribute to aggressive behavior in Chinese adolescents.

  2015cites this paper
• Serotonin and Dopamine Candidate Gene Variants and Alcohol- and Non-Alcohol-Related Aggression.

  2015cites this paper
• Genetic epidemiology of psychotic symptoms and their treatment in dementia

  2014cites this paper
• Behavioral genetics and criminal responsibility at the courtroom.

  2014cites this paper
• Nonamyloid PET biomarkers and Alzheimer's disease: current and future perspectives

  2014cites this paper
• Delusions in Alzheimer's Disease

  2014influential citation
• Neuropsychiatric aspects of dementia.

  2014cites this paper
• PET radiotracers for molecular imaging in dementia.

  2014cites this paper
• The effect of the serotonin transporter polymorphism (5-HTTLPR) on empathic and self-conscious emotional reactivity.

  2013cites this paper
• Brain-Specific Tryptophan Hydroxylase, TPH2, and 5-HTTLPR are Associated with Frontal Lobe Symptoms in Alzheimer's Disease

  2013cites this paper
• The role of the serotonergic system at the interface of aggression and suicide.

  2013cites this paper
• Ascending monoaminergic systems alterations in Alzheimer's disease. translating basic science into clinical care.

  2013cites this paper
• The 5-HTTLPR polymorphism in the serotonin transporter gene moderates the association between emotional behavior and changes in marital satisfaction over time.

  2013cites this paper
• 5-Hydroxytryptamine 2A receptor antagonists as potential treatment for psychiatric disorders

  2013cites this paper
• Behavioral genetics of neurodegenerative disorders.

  2012cites this paper
• Evaluation of the 5-HTTLPR and 5-HTTVNTR Polymorphisms in the Serotonin Transporter Gene in Women with Postpartum Depression

  2012cites this paper
• Altered serotonergic neurotransmission as a main player in the pathophysiology of Alzheimer's disease : structural and ultrastructural studies in a triple transgenic mouse model of the disease

  2012cites this paper
• Genetics of aggression.

  2012cites this paper
• Association of serotonin and dopamine gene pathways with behavioral subphenotypes in dementia.

  2012cites this paper
• Cerebral correlates of psychotic syndromes in neurodegenerative diseases

  2012cites this paper
• Effects of yokukansan on behavioral and psychological symptoms of vascular dementia: an open-label trial.

  2012cites this paper
• Functional analysis-based interventions for challenging behaviour in dementia.

  2012cites this paper
• A conceptual framework for rejection of care behaviors: review of literature and analysis of role of dementia severity.

  2012cites this paper
• Behavioral and pharmacogenetics of aggressive behavior.

  2012cites this paper
• The serotonergic system in ageing and Alzheimer's disease.

  2012cites this paper
• Missense substitutions associated with behavioural disturbances in Alzheimer's disease (AD).

  2012cites this paper
• ffects of yokukansan on behavioral and psychological symptoms of vascular ementia : An open-label trial

  2012cites this paper
• Citalopram for agitation in Alzheimer's disease: Design and methods

  2012cites this paper
• Influence of 5-HTTLPR and 5-HTTVNTR polymorphisms of the serotonin transporter gene (SLC6A4) on major depressive disorder in a sample of Argentinean population.

  2012cites this paper
• Genetic determinants of aggression and impulsivity in humans

  2012influential citation
• Serotonin transporter polymorphismen in VITA-Projekt

  2011cites this paper
• Neurobiology of Delusions in Alzheimer’s Disease

  2011cites this paper
• Brain serotonin receptors and transporters: initiation vs. termination of escalated aggression

  2011cites this paper
• The Role of 5-HT 2C Polymorphisms in Behavioral and Psychological Symptoms of Alzheimer Disease

  2011cites this paper
• Molecular psychogenetics of deviant aggressive behavior in humans

  2011cites this paper
• Genes of neUrotrAnsMitter systeMs And psyCho-eMotionAl feAtUres of hUMAn: serot onerGiC systeM

  2011cites this paper
• Emotion and Behavior in Alzheimer's Disease and Other Dementias

  2011cites this paper
• Depression and Alzheimer's Disease: Is Stress the Initiating Factor in a Common Neuropathological Cascade?

  2011cites this paper
• The role of G protein-coupled receptors in the pathology of Alzheimer's disease

  2011cites this paper
• Behavioural genetics of Alzheimer's disease: a comprehensive review

  2011influential citation
• Pimavanserin, a Serotonin2A Receptor Inverse Agonist, for the Treatment of Parkinson's Disease Psychosis

  2010cites this paper
• Management of behavioral problems in Alzheimer's disease

  2010influential citation
• Advances and perspectives from genetic research: development of biological markers in Alzheimer’s disease

  2010cites this paper
• Genetics of Psychosis in Alzheimer's Disease: A Review

  2010influential citation
• Serotonin transporter and saitohin genes in risk of Alzheimer’s disease and frontotemporal lobar dementia: preliminary findings

  2010cites this paper
• Serotonin transporter triallelic genotype and response to citalopram and risperidone in dementia with behavioral symptoms

  2010cites this paper
• Genetic susceptibility to behavioural and psychological symptoms in Alzheimer disease.

  2010cites this paper
• Serotonin and Aggression

  2010cites this paper
• TITLE Genes of the serotonergic and dopaminergic pathways and their interaction affect the expression of Behavioural and Psychological Symptoms in Dementia (BPSD): A Multiple Indicators Multiple Causes (MIMIC) approach.

  2009cites this paper
• The Serotonin Transporter Promoter Polymorphic Region is not a Risk Factor for Alzheimer's Disease Related Behavioral Disturbances

  2009cites this paper
• Pharmacological interventions in primary care: hopes and illusions.

  2009cites this paper
• Can dietary intervention help in management of problem behaviors in dementia?

  2009cites this paper
• Effect of yokukansan on the behavioral and psychological symptoms of dementia in elderly patients with Alzheimer's disease.

  2009cites this paper
• Altered Brain Serotonin Transporter and Associated Glucose Metabolism in Alzheimer Disease

  2009cites this paper
• Serotonergic system genes in psychosis of Alzheimer dementia: meta-analysis.

  2009cites this paper
• Genes of the serotonergic and dopaminergic pathways and their interaction affect the expression of Behavioural and Psychological Symptoms in Dementia (BPSD).

  2009cites this paper